Company
KAICO Ltd.
Established
April 2, 2018
Location
【Head office & GMP facility】
4-1, Kyudaishinmachi, Nishi ku, Fukuoka city, Fukuoka, 819-0388, Japan
【Office & Laboratory】
5-5, Kyudaishinmachi, Nishi ku, Fukuoka city, Fukuoka, 819-0388, Japan
【Satellite Laboratory】
1-1, Hyakunenkouen, Kurume city, Fukuoka, 839-0864, Japan
Tel
092-707-4016
FAX
092-707-4017
CEO
Kenta Yamato
Business scope
- Contract protein expression services
- Manufacture and sales of reagents and diagnostics.
- Development, manufacture, and sales of veterinary oral vaccines and feed additives.
- Development of oral vaccines for human use.
Major granted projects
- ”Aquaculture Growth Industrialization Pilot Project” by the Ministry of Agriculture, Forestry and Fisheries (FY 2022 ~ 2024)
- ”Deep-Tech Startups Support Program” by the New Energy and Industrial Technology Development Organization (FY 2023 ~ 2025)
- ”R&D Support Project for SMEs with Growth Potential (Go-Tech Project)” by the Ministry of Economy, Trade and Industry (FY 2022 ~ 2023)
- ”Program on R&D of New Generation Vaccine including New Modality Application” by the Japan Agency for Medical Research and Development / Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparation and Respond (FY 2022 ~ 2024)
Access
